Serviços em Medicina, Educação, Investigação, Desenvolvimento e Avaliação

Serviços em Medicina, Educação, Investigação, Desenvolvimento e Avaliação
medida - logo-medida-branco-1

Health conditions and target population approached by MEDIDA:

Cardiovascular: Adults diagnosed with hypertension or heart failure. Experienced adherence challenges are patient adherence to medications as many patients stops taking medications when “everything is fine”. Adults diagnosed with Heart Failure. Experienced adherence challenges are related to following medication regime.

Endocrinology: Adults diagnosed with Diabetes Type 2 on insulin regime. Experienced adherence challenges are patient adherence to therapeutic plan.

Neurology: Adults diagnosed with migraine or Spondylosis. Experienced adherence challenges are related to following medication regime due to side effects.

 

MEDIDA is a University of Porto spin-off. It is a small company that aims to improve (i) the quality of healthcare through R&D&I and (ii) the quality of life of patients with respiratory and allergic diseases by providing personalized healthcare services and solutions. MEDIDA is credited by the Portuguese government agency for innovation (ANI) for R&D services in health and in information and communication technologies applied to health

Health conditions and target population approached by MEDIDA:

Cardiovascular: Adults diagnosed with hypertension or heart failure. Experienced adherence challenges are patient adherence to medications as many patients stops taking medications when “everything is fine”. Adults diagnosed with Heart Failure. Experienced adherence challenges are related to following medication regime.

Endocrinology: Adults diagnosed with Diabetes Type 2 on insulin regime. Experienced adherence challenges are patient adherence to therapeutic plan.

Neurology: Adults diagnosed with migraine or Spondylosis. Experienced adherence challenges are related to following medication regime due to side effects.

 

MEDIDA is a University of Porto spin-off. It is a small company that aims to improve (i) the quality of healthcare through R&D&I and (ii) the quality of life of patients with respiratory and allergic diseases by providing personalized healthcare services and solutions. MEDIDA is credited by the Portuguese government agency for innovation (ANI) for R&D services in health and in information and communication technologies applied to health